Swarthmore Group’s Merck MRK Stock Holding History

Swarthmore Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,921	Closed	-$318K	–	44
2017 Q4	$318K	Sell	5,921 -577	-9%	-$32K	0.07%	44
2017 Q3	$397K	Buy	+6,498	New	+$394K	0.09%	43

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Swarthmore Group's MRK Position: Q1 2018 in Review

Swarthmore Group sold out of Merck (MRK) in Q1 2018, closing a stake of 5,921 shares — an estimated $318K sold.

Swarthmore Group first reported a position in MRK in Q3 2017 and held it in 2 quarters. The position peaked at $397K in Q3 2017. 1,992 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

Swarthmore Group reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
Swarthmore Group sold 5,921 Merck shares in Q1 2018, an estimated $318K.
Swarthmore Group first reported a position in Merck in Q3 2017 and held it in 2 quarters.
Swarthmore Group's Merck position peaked at $397K in Q3 2017.
1,992 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Swarthmore Group's 13F filing for Q1 2018, filed 12 Apr 2018.